Abstract:BackgroundCurcumin, extracted from the spice turmeric is commonly used in traditional Chinese and Indian medicine, has attracted increased interest for treating chronic inflammatory diseases owing to its antioxidant and anti-inflammatory properties. It has been reported that curcumin scavenges free radicals and their reactive metabolites due to its antioxidant activity, and blocks the free radical mediated inflammatory responses resulting in its anti-inflammatory activity. However, it has limited medical use due to its low oral bioavailability largely attributed to its low aqueous solubility. Its low intestinal adsorption is exacerbated by its rapid metabolism and excretion. Several approaches including the use of emulsions, micro-/nano-crystallised formulations, liposomes, cyclodextrin-complexes, conjugation with water soluble polymers, self-assembled particles and nanogels have been proposed to improve the oral bioavailability of curcumin. However, these approaches are difficult to manufacture in a large scale and require expensive machinery. The approach in the current work is to develop a cost-effective and scalable solid oral formulation of curcumin with enhanced bioavailability using water soluble polymers. MethodsCurcumin formulations were prepared through melt-granulation process. Curcumin was dissolved in polyethylene glycol (PEG) and PEG-block copolymer. A series of curcumin to PEG and PEG-block copolymer compositions were tested to maximise curcumin aqueous solubility. Loading of different curcuminoids in the formulation and their aqueous solubility was determined using HPLC along with their dissolution profile. The observations from the new curcumin formulations were compared to a commercially available curcumin product.ResultsDissolving curcumin in PEG can ensure its dispersion at molecular level in aqueous environments, the addition of PEG-bloc-copolymer can further stabilise this dispersion thus, resulted in the increased curcumin aqueous solubility. The results demonstrated that the new formulation can deliver 60mg of curcumin per capsule and showed faster and higher rate of release of curcumin in the soluble form both in simulated gastric conditions and intestinal conditions compared to the commercial comparator.ConclusionThe formulations showed enhanced dissolution and were relatively simple to produce. The PEG-block copolymer increased curcumin aqueous solubility by forming a water soluble complex with the drug. Future work involving in vivo supplementation studies are required to confirm these in vitro observations.

Development of an Antarctic krill oil based self-microemulsion drug delivery system and its enhancement of bioaccessibility for curcumin

Self-microemulsifying Drug Delivery System Improves Curcumin Dissolution and Bioavailability

Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems.

Enhanced Oral Bioavailability of [6]-Gingerol-smedds: Preparation, in Vitro and in Vivo Evaluation

Enhanced Antioxidant and Anti-Inflammatory Effects of Self-Nano and Microemulsifying Drug Delivery Systems Containing Curcumin

Formulation optimization of solid self-microemulsifying pellets for enhanced oral bioavailability of curcumin

Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: formulation and bioavailability studies.

Enhanced Oral Bioavailability of Daidzein by Self-Microemulsifying Drug Delivery System

Development of curcumin formulations with enhanced bioavailability for oral drug delivery

Fabrication of Emulsions Using High Loaded Curcumin Nanosuspension Stabilizers: Enhancement of Antioxidant Activity and Concentration of Curcumin in Micelles

Preparation and Characterization of Microemulsions Based on Antarctic Krill Oil

Optimisation of Curcumin Microemulsions Using Palm Oil

Improved Oral Bioavailability and Hypolipidemic Effect of Syringic Acid via a Self-microemulsifying Drug Delivery System

Enhanced Bioavailability of Total Paeony Glycoside by Self-Microemulsifying Drug Delivery System.

Self-microemulsifying drug-delivery system for improved oral bioavailability of 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol: preparation and evaluation

Design and optimization of self-nanoemulsifying formulations for lipophilic drugs.

Development of Self-Microemulsifying Drug Delivery Systems for Oral Bioavailability Enhancement of Alpha-Asarone in Beagle Dogs.

Fabrication and Optimization of Self-Microemulsions to Improve the Oral Bioavailability of Total Flavones of Hippophaë rhamnoides L

Enhanced oral bioavailability of Bisdemethoxycurcumin-loaded self-microemulsifying drug delivery system: Formulation design, in vitro and in vivo evaluation

Construction and Digestive Characterization of Emulsions Stabilized with Octenyl Succinic Anhydride-Modified Curdlan.

Self-microemulsifying Drug Delivery System for Improved Oral Bioavailability of Oleanolic Acid: Design and Evaluation.